These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38942021)

  • 1. Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives.
    Chen W; Li Y; Wang W; Gao S; Hu J; Xiang B; Wu D; Jiao N; Xu T; Zhi M; Zhu L; Zhu R
    Cell Rep Med; 2024 Jul; 5(7):101624. PubMed ID: 38942021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease.
    Hu J; Cheng S; Yao J; Lin X; Li Y; Wang W; Weng J; Zou Y; Zhu L; Zhi M
    Front Immunol; 2022; 13():947313. PubMed ID: 36045690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
    Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
    J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Basson AR; Gomez-Nguyen A; Menghini P; Buttó LF; Di Martino L; Aladyshkina N; Osme A; LaSalla A; Fischer D; Ezeji JC; Erkkila HL; Brennan CJ; Lam M; Rodriguez-Palacios A; Cominelli F
    Inflamm Bowel Dis; 2020 Feb; 26(3):347-359. PubMed ID: 31750921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn's disease - a preliminary study.
    Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Niemira M; Zeber-Lubecka N; Zagorowicz E; Kretowski A; Ostrowski J
    BMC Gastroenterol; 2020 Sep; 20(1):307. PubMed ID: 32958038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.
    Dunn KA; Moore-Connors J; MacIntyre B; Stadnyk A; Thomas NA; Noble A; Mahdi G; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    Inflamm Bowel Dis; 2016 Nov; 22(11):2607-2618. PubMed ID: 27760077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
    J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
    Ijaz UZ; Quince C; Hanske L; Loman N; Calus ST; Bertz M; Edwards CA; Gaya DR; Hansen R; McGrogan P; Russell RK; Gerasimidis K
    PLoS One; 2017; 12(2):e0172605. PubMed ID: 28222161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects.
    Ozturk O; Celebi G; Duman UG; Kupcuk E; Uyanik M; Sertoglu E
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):890-896. PubMed ID: 38829943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress.
    Mackner LM; Hatzakis E; Allen JM; Davies RH; Kim SC; Maltz RM; Bailey MT
    Psychoneuroendocrinology; 2020 Jan; 111():104469. PubMed ID: 31654986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.